TMSB10

Thymosin beta-10 · P63313 · TMSB10 on Sugi Atlas →

0 patent compounds predicted against TMSB10, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TMSB10 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Vitamin D for the Treatment of Severe Asthma PHASE4UNKNOWN
Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK PHASE3COMPLETED
IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101) PHASE1/PHASE2COMPLETED
Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK PHASE2RECRUITING
Skin Test Study of BM32 PHASE1/PHASE2COMPLETED
A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease PHASE2COMPLETED
NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS) PHASE1/PHASE2COMPLETED
Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis PHASE1/PHASE2WITHDRAWN
Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type PHASE2UNKNOWN
Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation nanCOMPLETED
Study of Genotype and Phenotype Characterization in Duchenne Muscular Dystrophy With Small Mutations nanUNKNOWN
TL1A Expression in Psoriatic Skin nanUNKNOWN
Deficient T Regulatory Cell (Treg) Function in Patients With Relapsing Remitting Multiple Sclerosis nanUNKNOWN
Differential Expression of CD200 in B-chronic Lymphoproliferative Disorders by Multicolour Flow Cytometry nanUNKNOWN
Assessment of FOXP3 Gene Polymorphisms and Serum Interleukin 10 in Patients With ITP nanUNKNOWN
Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism nanUNKNOWN
The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology. nanRECRUITING
Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) Immunotherapy nanUNKNOWN
Biology of Thymic Tumors nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies nanRECRUITING
Cerebellar Mutism Syndrome Study nanRECRUITING
Effect of Perioperative Neurostimulation in Patients Undergoing Whipple Operation (Pancreaticoduodenectomy) on Acute Postsurgical Inflammatory Response [ENSWAPI-trial] nanUNKNOWN
Impact of Thymectomy on Immunity in Infants After Cardiac Surgery nanRECRUITING
Correlation Between Vaspin Gene Polymorphism and Serum Vaspin Levels in Psoriasis Vulgaris nanRECRUITING
Impact of the Ex-vivo Pulmonary Perfusion System on the Microbiome of Lung Grafts and Their Inflammatory Reaction. nanUNKNOWN
The Genetic Characterization of Dementia nanCOMPLETED
Genetic Contribution of Pain and Inflammation in IBS nanCOMPLETED
Possible Diagnostic Protein Markers in Schistosoma Related Bladder Diseases. nanNOT_YET_RECRUITING
Exploratory Evaluation of Biomarkers Associated With Treatment Response to Cosentyx (Secukinumab) in Psoriasis Patients nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a TMSB10 binder may also engage these)

ProteinNameSimilarity
P63314 1.000 P63314 →
P63312 1.000 P63312 →
Q6ZWY8 1.000 Q6ZWY8 →
P33248 0.996 P33248 →
P0CG34 0.995 P0CG34 →
P34032 0.995 P34032 →
P0DX04 0.995 P0DX04 →
Q6S9C5 0.994 Q6S9C5 →
P62329 0.994 P62329 →
P10430 0.993 P10430 →
P0CG35 0.992 P0CG35 →
P21753 0.992 P21753 →
P21752 0.992 P21752 →
Q9I954 0.991 Q9I954 →
Q9DET5 0.990 Q9DET5 →
Q9RMY0 0.990 Q9RMY0 →
Q81DD0 0.990 Q81DD0 →
P26352 0.990 P26352 →
Q9I980 0.989 Q9I980 →
P44588 0.989 P44588 →
P56618 0.989 P56618 →
B7HLK3 0.989 B7HLK3 →
C1EP94 0.989 C1EP94 →
Q7YRC3 0.988 Q7YRC3 →
P18758 0.988 P18758 →
C0H3W7 0.988 C0H3W7 →
M1YW29 0.988 M1YW29 →
TMSB4X Thymosin beta-4 0.988 landscape →
Q5R7H8 0.988 Q5R7H8 →
Q9I955 0.988 Q9I955 →